Bilatteral Acute Angle Closure Glaucoma

Embed Size (px)

Citation preview

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    1/17

    Ahmed ALgihady

    Resident ,DHO

    A case report

    Bilateral acute onset angle closure glaucoma after oral topiramate

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    2/17

    A 40-year-old female was seen in

    our emergency department with

    Two days history of severe

    headache,

    Painful red eyes, Bilateral blurring of vision with

    photophobia.

    She was a known sufferer of

    migraine but had no previous

    ocular problems and had neverrequired glasses.

    Personal history and Complaints

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    3/17

    There was no ocular disease of

    significance within the family history.

    She had no history of drug allergy.

    Four days prior to the onset of her ocular

    problems, she consulted a neurologist and

    started a daily dose of25mg Topiramate

    for her migraine.

    Family, past history and medications

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    4/17

    Examination- signs

    OSOD

    3/603/60Visual acuity

    normalnormalEye lid

    Edema & circum

    corneal

    congestion

    Edema & circum

    corneal

    congestion

    Conjctivia

    edemaedemaCornea

    ShallowShallowAC

    59 mmhg54 mmhgIOP

    Mid dilated fixedMid dilated fixedPupil

    Slit lamp biomic

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    5/17

    Roughly seen due to hazy media by corneal edema but

    bilateral optic disc edema and hyperemia is noted more

    evident on the left eye with healthy rim tissue and 0.2-

    0.3 cup to disc ratios in both eyes. Query mild choroidal

    effusion is suspected.

    Fundus Examination

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    6/17

    B scan on the next

    day revealed

    choroidal thickening

    which correlates withchoroidal effusion.

    B - scan ultrasonography

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    7/17

    Differential Diagnosis of causes of bilateral ACG

    It is a rare entity but it is usually

    precipitated by an external factor

    mostly drugs.

    Suspicion for medication

    induced angle closure glaucomashould be higher whenever

    angle closure presents

    bilaterally.

    Examples to reported drugs

    include: Venalexine, general

    anaesthetics, Citalopram ,

    flavoxate, paroxetine,

    trimethoprim, sulfamethoxazole

    and Topiramate.

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    8/17

    There was no ocular

    disease of significance

    within the family

    history.

    She had no history ofdrug allergy.

    Four days prior to the

    onset of her ocular

    problems, she

    consulted a neurologist

    and started a daily dose

    of

    25 mg Topiramate

    for her migraine.

    Family, past history and medications

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    9/17

    1- Aggressive topical

    aqueous suppressants

    (B-blockerantiglaucomatous eye

    drops; Timolol 0.5%)

    2- IV mannitol (1mg/kg)

    3- Dexamethasone eye

    drops.

    Withdrawal of the drug-4

    with referral to her

    neurologist.

    Management

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    10/17

    Follow up visits

    sluggish mid dilated pupils)(glaucomfleckenpupil

    gradual decrease in intraocular pressure from 24

    mmHg on the second day to 7.5 mmHg within 10

    days of follow up

    IOP

    the visual acuity also improved from3/60 OU within 2 days of management to 6/18 OD

    and 6/36 OS within 10 days of follow up

    V/A

    10 days

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    11/17

    Fundus examination

    was normal and optic

    disc congestion wasreduced within 10

    days.

    Follow up visits

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    12/17

    Follow up visits

    Improvement of visual acuity and IOP

    OSOD

    6/96/6Visual acuity

    16.

    5 mmgh12 mmghIOPMid dilated fixedMid dilated fixedPupil

    refraction

    OSOD

    axiscylSph

    0.00+0.25

    24+0.75+0.25

    Follow up visits (after1 month)

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    13/17

    Follow up visits (after1 month)

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    14/17

    Topiramateis an oral sulphamate

    medication primarily used forseizure, migraine and

    neuropathic pain.

    It has been associated with

    secondary angle closure, whichcan mimic acute angle closure

    glaucoma and myopia .

    Topamax

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    15/17

    Topiramatewas first implicated as a

    cause of bilateral acute angle closureglaucoma in 2001. A recent review of

    case reports of adverse effects of

    topiramate use revealed abnormal

    vision, acute secondary angle closure

    glaucoma, acute myopia andsuprachoroidal effusions.

    The proposed mechanism of myopia and

    secondary angle closure is choroidal

    effusion and forward rotation of the iris-

    lens diaphragm. The effusion places

    pressure on the vitreous body andcompresses the lens-iris diaphragm,

    causing anterior displacement and

    closure of the angle.

    Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate induced bilateral acute angle closure glaucoma.

    Am J Ophthalmol2001; 132: 112-114.

    FraunfelderFW, Fraunfelder FT, Keates EU. Topiramate associated acute, bilateral, secondary angle closure glaucoma.Ophthalmology 2004; 111: 109-111.

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    16/17

    The treatment for topiramate

    induced secondary angle closure

    are cycloplegia and topical

    corticosteroids.

    Cycloplegia relaxes the ciliary

    body and tighten the zonules,

    keeping the iris-lens diaphragm in

    check.

    Most cases of topiramate-

    associated angle-closure

    glaucoma present within the first 2weeks of treatment but reactions

    have been reported within hours

    of the first dose or as long as

    seven weeks after onset of

    therapy.

  • 8/9/2019 Bilatteral Acute Angle Closure Glaucoma

    17/17

    Thank you